HKSE - Delayed Quote HKD

SINO BIOPHARM (1177.HK)

3.910
+0.030
+(0.77%)
At close: May 9 at 4:08:05 PM GMT+8
All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
6,615,120
6,615,120
6,065,734
6,265,155
5,366,294
Investing Cash Flow
-1,709,126
-1,709,126
-756,975
-4,070,819
-2,515,977
Financing Cash Flow
-6,315,086
-6,315,086
-6,548,990
-3,186,390
-3,225,263
End Cash Position
6,231,523
6,231,523
7,505,098
8,654,805
9,599,537
Capital Expenditure
-1,394,160
-1,394,160
-1,703,709
-1,705,612
-1,893,984
Issuance of Capital Stock
150,674
150,674
--
--
--
Issuance of Debt
11,695,985
11,695,985
12,193,884
9,752,976
1,406,044
Repayment of Debt
-14,431,043
-14,431,043
-13,905,936
-8,703,851
-2,826,814
Repurchase of Capital Stock
-1,252,200
-1,252,200
-396,393
-867,613
-332,930
Free Cash Flow
5,220,960
5,220,960
4,362,025
4,559,543
3,472,310
12/31/2021 - 5/12/2004

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers